Article

Dietary algae and HIV/AIDS: Proof of concept clinical data

Journal of Applied Phycology (Impact Factor: 2.49). 06/2012; 24(3):575-582. DOI: 10.1007/s10811-011-9766-0
Source: PubMed

ABSTRACT Dietary algae have been reported to decrease HIV viral fusion/entry and replication and increase immune response, suggesting that regular consumption of algae by people in Japan, Korea, and Chad could be an important factor in their relatively low HIV/AIDS rates. Five antiretroviral-naïve people with HIV (three females, two males; five African Americans) living in Columbia SC participated in the phase I study of acute toxicity. Subjects were randomly assigned to 5 g day(-1) brown seaweed (Undaria pinnatifida), Spirulina (Arthrospira platensis), or a combination of both. Endpoints included HIV viral load, complete blood count (CBC), metabolic and lipid panel, and quality of life questionnaire data. When no short-term toxicities were observed, six additional subjects (four females, two males; five African Americans, one Latina) were recruited to further evaluate short- and long-term toxicities (phase II). No adverse effects were observed for the 11 subjects in the phase I trial, and quality of life indicators improved at 3 weeks. No significant changes were observed in CBC, metabolic or lipid panel analyses. CD4 cells (milliliters) and HIV-1 viral load remained stable over the first 3-month phase II study period. One subject continued in the study for 13 months and had clinically significant improvement in CD4 (>100 cells mL(-1)) and decreased HIV viral load of 0.5 log(10). Our pilot data suggest that Undaria, Spirulina, and a combination of both were nontoxic and over time may improve clinical endpoints of HIV/AIDS.

Download full-text

Full-text

Available from: Mohammad R Irhimeh, Apr 19, 2014
2 Followers
 · 
160 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A short questionnaire was devised during the 4th ISAP Conference in Halifax (2011) to gather some information on the algal eating habits of the participants. Responses were also collected from random members of the general public in Galway and Copenhagen. Most phycologists had eaten algae before (93%), but few conference participants ate it more regularly than per month. Responses of the general public were similar. A probability model tested the likelihood of a participant eating algae. Neither age nor nationality significantly influenced this probability, although gender increased the probability of eating algae regularly by 9% if the participant was male (at the 90% confidence limit). As hypothesised, being a conference attendee highly significantly increased the probability of eating algae by 22%, in comparison with non-conference attendees (i.e. the general public). The type of phycological research studied also had a significant effect. Researchers working with macroalgae were 22% more likely to eat algae, whereas microalgal researchers were 15% less likely to eat algae on a monthly or more regular basis. The main reasons for eating algae by both groups were ‘taste’, followed by ‘other’ (undefined) reasons, whereas the main reason for not eating algae in both groups was a ‘lack of availability’. Phycologists also ate algae for the perceived ‘health benefits’ (36%), whereas few members of the general public chose this option (13%). Consumption of red seaweeds was most popular (60% of phycologists and 71% of the general public), with Porphyra spp. most commonly preferred. In total, 27 genera of macroalgae and microalgae were recorded as eaten by questionnaire participants.
    Journal of Applied Phycology 06/2011; 24(3). DOI:10.1007/s10811-011-9760-6 · 2.49 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Significance: Oxidative stress resulting from excessive reactive oxygen/nitrogen/electrophilic species (ROS/RNS/RES) can lead to diseases such as cancer. The health benefits of dietary fruits and vegetables with antioxidant potential have received a great deal of attention. On the other hand, marine botanicals have been less well characterized and still remain as terra incognita. Recent Advances: In some parts of the world, appreciable quantities of seaweeds are consumed on a daily basis. Along with current globalization, cuisines using seaweeds are now being used throughout the world, sometimes considered as healthy delicacies. Thus, it is relevant to explore the medicinal and pharmacological properties of seaweeds, as well as the health ramifications of this dietary practice. Critical Issues: We currently review the antioxidant potential of seaweed components such as sulfated polysaccharides, phenolic compounds (phlorotannins, bromophenols), and fucoxanthins. In addition to seaweeds, the chemistry and antioxidant activities of some marine fungi and bacteria are described. Since antioxidants are considered promising cancer chemopreventive agents, the in vitro, in vivo and clinical aspects of antioxidant marine products are presented, and potential implications are discussed. Future Directions: Although some data suggest health benefits are derived from the consumption of marine natural products, further epidemiological or clinical studies are needed to strengthen these observations. In addition, many studies have demonstrated antioxidant effects of seaweeds with in vitro models, but further characterization of bioavailability is necessary to suggest the significance of these responses. It is also important to define the safety of some seaweed containing inorganic arsenics.
    Antioxidants & Redox Signaling 02/2013; 19(2). DOI:10.1089/ars.2013.5235 · 7.67 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Daily consumption of seaweed has been proposed as a factor in explaining lower postmenopausal breast cancer (BC) incidence and mortality rates in Japan. This clinical trial assessed the impact of introducing seaweed- to non-seaweed-consuming American postmenopausal women. Fifteen healthy postmenopausal women were recruited for a 3-month single-blinded placebo controlled clinical trial; five had no history of BC (controls) and ten were BC survivors. Participants ingested ten capsules daily (5 g day(-1)) of placebo for 4 weeks, seaweed (Undaria) for 4 weeks, then placebo for another 4 weeks. Blood and urine samples were collected after each treatment period. Urinary human urokinase-type plasminogen activator receptor concentrations (uPAR) were analyzed by ELISA, and urine and serum were analyzed for protein expression using surface-enhanced laser desorption/ionization-time-of-flight mass spectrometry (SELDI-TOF-MS). Urinary creatinine standardized uPAR (in pg mL μg(-1) creatinine) changed significantly between groups, decreasing by about half following seaweed supplementation (placebo 1, 1.5 (95 % CI, 0.9-2.1) and seaweed, 0.9 (95 % CI, 0.6-1.1) while placebo 2 returned to pre-seaweed concentration (1.7 (95 % CI, 1.2-2.2); p = 0.01, ANOVA). One SELDI-TOF-MS-identified urinary protein (m/z 9,776) showed a similar reversible decrease with seaweed and is reported to be associated with cell attachment. One serum protein (m/z 8,928) reversibly increased with seaweed and may be the immunostimulatory complement activation C3a des-arginine. uPAR is higher among postmenopausal women generally, and for BC patients, it is associated with unfavorable BC prognosis. By lowering uPAR, dietary seaweed may help explain lower BC incidence and mortality among postmenopausal women in Japan.
    Journal of Applied Phycology 06/2013; 25(3):771-779. DOI:10.1007/s10811-012-9931-0 · 2.49 Impact Factor
Show more